To determine if CAR-T-mediated CD22 on-target and off-target antigen modulation was a lasting effect, CAR-T and leukemia cells were separated following overnight co-culture using anti-CD3 immunomagnetic beads, and leukemia cells cultured alone in fresh media. The gene discussed is CD22; the disease is leukemia.